FDA 483 & WARNING LETTER RESPONSE

When the FDA escalates, we respond with you.

Confidential FDA 483 and Warning Letter response for biopharma, medical-device, and gene & cell therapy manufacturers. 500+ regulatory inspections — flawless record. Senior practitioners on every engagement. First call is free.

(919) 351-6541
  • Pfizer
  • Johnson & Johnson
  • Abbott
  • Bristol Myers Squibb

Request a Confidential Consultation

Takes 60 seconds 100% confidential

  • FDA Form 483 / observation letter
  • FDA Warning Letter
  • Inspection pending or underway
  • CAPA or remediation program
  • GMP audit / mock inspection
  • 510(k) / PMA / de novo submission
  • Other quality / regulatory work
  • We have an active letter — need help fast
  • Inspection coming in the next 30 days
  • Preparing proactively, no active issue
  • Exploring options

Request Received

Thank you. A senior advisor will contact you within one business day. Your information is held in strict confidence.

100% Secure & Confidential
The Practice
500+
Regulatory inspections — flawless record
200+
New product launches supported
13
Global regulatory bodies, including FDA
In Good Company

Trusted by life-sciences manufacturers that can’t afford to fail an FDA inspection.

  • Baxter
  • Edwards Lifesciences
  • Clorox
  • MCS Healthcare
  • Evertec
Why LaSalle

Why quality & regulatory leaders pick LaSalle

Senior practitioners — not junior staff — on every engagement. Fast, confidential, and written to survive the follow-up inspection.

FDA + 12 Other Regulators

Our senior consultants have shepherded submissions through the FDA and twelve other global regulatory bodies across 35+ years in life-sciences operations.

Integrated, Not Siloed

Quality and regulatory rarely live alone. Our consultants cover operations, transformation, and people alongside — so a 483 response also stabilizes the system that produced it.

No Cookie-Cutter Engagements

Every project is a personalized plan. 97% of our transformations hold up over time — versus the industry average of 70% that don't.

Start the Conversation

Got an FDA letter on your desk?

Call now for a confidential first conversation — or scroll up and request one in under a minute.

(919) 351-6541 or Fill out the form above